First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

• Samuel L Cytryn
• , Ryan H Moy
• , Darren Cowzer
• , Ronak H Shah
• , Joanne F Chou
• , Smita S Joshi
• , Geoffrey Y Ku
• , Steven B Maron
• , Avni Desai
• , Jessica Yang
• , Ryan Sugarman
• , Devika Rao
• , Zoe Goldberg
• , Carmelina Charalambous
• , Maria Lapshina
• , Ariel Antoine
• , Fiona Socolow
• , Nikhil Trivedi
• , Marinela Capanu
• , Hans Gerdes
• , Mark A Schattner
• , Marc Simmons
• , Mario E Lacouture
• , Viktoriya Paroder
• , Laura H Tang
• , Jinru Shia
• , David H Ilson
• , David B Solit
• , Michael F Berger
• , Yelena Y Janjigian